Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma-Reference-Cited by-同舟云学术

Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma

Published:2023-11-23 Issue:21 Volume:389 Page:1961-1971
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Loriot Yohann¹,Matsubara Nobuaki¹,Park Se Hoon¹,Huddart Robert A.¹,Burgess Earle F.¹,Houede Nadine¹,Banek Severine¹,Guadalupi Valentina¹,Ku Ja Hyeon¹,Valderrama Begoña P.¹,Tran Ben¹,Triantos Spyros¹,Kean Yin¹,Akapame Sydney¹,Deprince Kris¹,Mukhopadhyay Sutapa¹,Stone Nicole L.¹,Siefker-Radtke Arlene O.¹

Affiliation:

1. From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) — all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan...

Funder

Janssen Research and Development

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2308849

Reference15 articles.

1. Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

2. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

3. Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer